Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Gross Profit (2024 - 2025)

Historic Gross Profit for Celldex Therapeutics (CLDX) over the last 6 years, with Q3 2025 value amounting to -$1.1 million.

  • Celldex Therapeutics' Gross Profit fell 14992.91% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 14971.64%. This contributed to the annual value of $1.8 million for FY2013, which is 31615.93% up from last year.
  • As of Q3 2025, Celldex Therapeutics' Gross Profit stood at -$1.1 million, which was down 14992.91% from -$814000.0 recorded in Q2 2025.
  • In the past 5 years, Celldex Therapeutics' Gross Profit ranged from a high of $2.1 million in Q3 2024 and a low of -$1.5 million during Q1 2025